Cargando…

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy

Detalles Bibliográficos
Autores principales:	Meloni, Antonella, Pistoia, Laura, Ricchi, Paolo, Allò, Massimo, Rosso, Rosamaria, Cuccia, Liana, Casini, Tommaso, Cecinati, Valerio, Serra, Marilena, Rossi, Vincenza, Righi, Riccardo, Renne, Stefania, Vallone, Antonino, Positano, Vincenzo, Cademartiri, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196914/ https://www.ncbi.nlm.nih.gov/pubmed/36332057 http://dx.doi.org/10.1182/bloodadvances.2022008805

Ejemplares similares

Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2023)

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
por: Meloni, Antonella, et al.
Publicado: (2023)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
por: Meloni, Antonella, et al.
Publicado: (2023)

P1459: CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

Gender Differences in Knowledge and Perception of Cardiovascular Disease among Italian Thalassemia Major Patients
por: Meloni, Antonella, et al.
Publicado: (2022)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

P1514: MULTI-PARAMETRIC CARDIAC MAGNETIC RESONANCE FOR RISK PREDICTION OF HEART FAILURE DEATH IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Left Ventricle Detection from Cardiac Magnetic Resonance Relaxometry Images Using Visual Transformer
por: De Santi, Lisa Anita, et al.
Publicado: (2023)

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
por: Meloni, Antonella, et al.
Publicado: (2023)

P1513: LOW VITAMIN D LEVELS ARE ASSOCIATED WITH INCREASED CARDIAC IRON UPTAKE IN THALASSEMIA MAJOR.
por: Meloni, A., et al.
Publicado: (2022)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

P1467: THE EMPLOYMENT OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY Β-THALASSEMIA: A MULTICENTER ANALYSIS FROM THE EXTENSION-MYOCARDIAL IRON OVERLOAD IN THALASSEMIA NETWORK (E-MIOT)
por: Raso, Simona, et al.
Publicado: (2023)

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
por: Meloni, Antonella, et al.
Publicado: (2023)

Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

P1515: IMPACT OF GENOTYPE ON PANCREATIC IRON OVERLOAD AND IMPAIRED GLUCOSE METABOLISM IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

P1512: HEART FAILURE IN THALASSEMIA MAJOR: TIME FOR NEW CARDIOVASCULAR MAGNETIC RESONCE MARKERS?
por: Meloni, A., et al.
Publicado: (2022)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy
por: Spasiano, Anna, et al.
Publicado: (2021)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications
por: Meloni, Antonella, et al.
Publicado: (2021)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Left ventricular global function index and left ventricular mass volume ratio by CMR: relation with heart failure in Thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2015)

Beliefs about chelation among thalassemia patients
por: Trachtenberg, Felicia L, et al.
Publicado: (2012)

Thalassemia and hepatocellular carcinoma: links and risks
por: Marsella, Maria, et al.
Publicado: (2019)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
por: Ricchi, Paolo, et al.
Publicado: (2015)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
por: Eziefula, Chinea, et al.
Publicado: (2022)

Successful chelation in beta-thalassemia major in the 21(st) century
por: Fragodimitri, Christina, et al.
Publicado: (2023)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort
por: Casale, Maddalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5antlkivl0gchqlh2esaom7cqd